Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced that Managed Waste Service plans to implement INBS' Intelligent Fingerprinting Drug Screening System across its New South Wales ...

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening ...

Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced an update on its growing footprint in the U.S. Forensic Use Only Market on Wednesday through its strategic partnership with SMARTOX. SMARTOX, ...

Intelligent Bio Solutions partners with Spjotgard to enhance fingerprint drug testing adoption in Scandinavia, addressing rising demand for non-invasive solutions. Intelligent Bio Solutions Inc.

Intelligent Bio Solutions INBS recently expanded its U.S. forensic market presence through a strategic partnership with SMARTOX, a Texas-based leader in drug and alcohol screening services. The ...

NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing ...

NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...

The new customer account represents one of INBS's most significant UK commercial deployments to date, the company said. Intelligent Bio’s Intelligent Fingerprinting Drug Screening System uses ...

NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

Intelligent Bio Solutions expands U.S. forensic market reach through a partnership with SMARTOX. The deal boosts INBS's fingerprint drug screening use in courts, prisons, and rehab centers.